The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.

Staszewski, Schlomo; Babacan, Errol; Stephan, Christoph; Haberl, Annette; Carlebach, Amina; Gute, Peter; Klauke, Stephan; Hermschulte, Yvonne; Stuermer, Martin; Dauer, Brenda

Staszewski, Schlomo; Babacan, Errol; Stephan, Christoph; Haberl, Annette; Carlebach, Amina; Gute, Peter; Klauke, Stephan; Hermschulte, Yvonne; Stuermer, Martin; Dauer, Brenda.

Affiliation

Staszewski S; Medical HIV Treatment & Research Unit, Hospital of the Johann Wolfgang Goethe University, Frankfurt, Germany.

J Antimicrob Chemother ; 58(5): 1024-30, 2006 Nov.

Article in En | MEDLINE | ID: mdl-16956902

Subject(s)

HIV Infections/drug therapy; HIV Protease Inhibitors/administration & dosage; HIV/growth & development; Pyrimidinones/administration & dosage; Ritonavir/administration & dosage; Saquinavir/administration & dosage; Adult; Aged; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes/immunology; Cohort Studies; Drug Interactions; Female; HIV/genetics; HIV Infections/immunology; HIV Infections/virology; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones/adverse effects; Pyrimidinones/pharmacokinetics; Ritonavir/adverse effects; Ritonavir/pharmacokinetics; Salvage Therapy; Saquinavir/adverse effects; Saquinavir/pharmacokinetics; Viral Load

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / HIV Infections / HIV / HIV Protease Inhibitors / Ritonavir / Saquinavir Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Antimicrob Chemother Year: 2006 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links